Bicycle Therapeutics Operating Cycle Over Time
| BCYC Stock | USD 6.00 0.49 7.55% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Bicycle Therapeutics Performance and Bicycle Therapeutics Correlation. Will Biotechnology sector continue expanding? Could Bicycle diversify its offerings? Factors like these will boost the valuation of Bicycle Therapeutics. Projected growth potential of Bicycle fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bicycle Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (3.62) | Revenue Per Share | Quarterly Revenue Growth 3.385 | Return On Assets | Return On Equity |
The market value of Bicycle Therapeutics is measured differently than its book value, which is the value of Bicycle that is recorded on the company's balance sheet. Investors also form their own opinion of Bicycle Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Bicycle Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Bicycle Therapeutics' market value can be influenced by many factors that don't directly affect Bicycle Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Bicycle Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bicycle Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Bicycle Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Operating Cycle Analysis
Compare Bicycle Therapeutics and related stocks such as RAPT Therapeutics, Neumora Therapeutics, and Omeros Operating Cycle Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RAPT | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| NMRA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| OMER | 36.0634 | 70.6764 | 117 | 86.4594 | 273 | 342 | 397 | 247 | 37.7 K | 273 | 306 | 306 | 306 | 306 | 306 | 275 | 262 |
| LXRX | 263 | 69.0914 | 462 | 130 | 36.0066 | 2.5575 | 32.8135 | 394 | 720 | 543 | 6.0085 | 17.1477 | 73.5252 | 309 | 178 | 160 | 110 |
| KALV | 60.9189 | 60.9189 | 60.9189 | 60.9189 | (10.3711) | 60.9189 | 618 | 297 | 256 | 475 | (10.3711) | (10.3711) | (10.3711) | (10.3711) | (10.3711) | (9.33) | (8.87) |
| ADCT | 391 | 391 | 391 | 391 | 391 | 391 | 391 | 391 | 123 | 443 | 3.3 K | 3.3 K | 1.5 K | 2.5 K | 1.2 K | 1.1 K | 1.1 K |
| PRTA | 28.2384 | 28.2384 | 28.2384 | 30.504 | (4.072) | 112 | 61.0394 | 2.5322 | 0.7644 | 30.4914 | 6.4185 | 0.0237 | 0.4198 | 20.6089 | 20.6089 | 23.7 | 26.53 |
| FDMT | 20.2358 | 20.2358 | 20.2358 | 20.2358 | 20.2358 | 20.2358 | 20.2358 | 20.2358 | 29.0347 | 51.0979 | 39.8465 | 0.951 | 81.6555 | 81.6555 | 81.6555 | 73.49 | 77.16 |
| FULC | 375 | 375 | 375 | 375 | 375 | 375 | 375 | 375 | 152 | 529 | 94.794 | 75.8067 | 62.2146 | 293 | 15.2479 | 17.54 | 16.66 |
| CMPX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Bicycle Therapeutics and related stocks such as RAPT Therapeutics, Neumora Therapeutics, and Omeros Operating Cycle description
My Equities
My Current Equities and Potential Positions
| Bicycle Therapeutics | BCYC |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | Portway Building, Cambridge, |
| Exchange | NASDAQ Exchange |
USD 6.0
Check out Bicycle Therapeutics Performance and Bicycle Therapeutics Correlation. For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Bicycle Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.